English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 89 | Tables: 170 | Medical Care
The global Posterior Segment Eye Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Posterior Segment Eye Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Posterior Segment Eye Disease Treatment.
Report Scope
The Posterior Segment Eye Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Posterior Segment Eye Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Posterior Segment Eye Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Santen Pharmaceuticals
Abbvie Inc.
Bausch Health Companies Inc.
F Hoffmann-La Roche
Merck & Co. Inc.
Novartis AG
Alcon Inc.
Rainbow Medical Ltd
Regeneron Pharmaceuticals Inc.
Second Sight Medical Products Inc.
Aerie Pharmaceuticals
Segment by Type
Medical Treatement
Operation
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Posterior Segment Eye Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Posterior Segment Eye Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medical Treatement
1.2.3 Operation
1.3 Market by Application
1.3.1 Global Posterior Segment Eye Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Posterior Segment Eye Disease Treatment Market Perspective (2019-2030)
2.2 Posterior Segment Eye Disease Treatment Growth Trends by Region
2.2.1 Global Posterior Segment Eye Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Posterior Segment Eye Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Posterior Segment Eye Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Posterior Segment Eye Disease Treatment Market Dynamics
2.3.1 Posterior Segment Eye Disease Treatment Industry Trends
2.3.2 Posterior Segment Eye Disease Treatment Market Drivers
2.3.3 Posterior Segment Eye Disease Treatment Market Challenges
2.3.4 Posterior Segment Eye Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Posterior Segment Eye Disease Treatment Players by Revenue
3.1.1 Global Top Posterior Segment Eye Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Posterior Segment Eye Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Posterior Segment Eye Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Posterior Segment Eye Disease Treatment Revenue
3.4 Global Posterior Segment Eye Disease Treatment Market Concentration Ratio
3.4.1 Global Posterior Segment Eye Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Posterior Segment Eye Disease Treatment Revenue in 2023
3.5 Posterior Segment Eye Disease Treatment Key Players Head office and Area Served
3.6 Key Players Posterior Segment Eye Disease Treatment Product Solution and Service
3.7 Date of Enter into Posterior Segment Eye Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Posterior Segment Eye Disease Treatment Breakdown Data by Type
4.1 Global Posterior Segment Eye Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Posterior Segment Eye Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Posterior Segment Eye Disease Treatment Breakdown Data by Application
5.1 Global Posterior Segment Eye Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Posterior Segment Eye Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Posterior Segment Eye Disease Treatment Market Size (2019-2030)
6.2 North America Posterior Segment Eye Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024)
6.4 North America Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Posterior Segment Eye Disease Treatment Market Size (2019-2030)
7.2 Europe Posterior Segment Eye Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Posterior Segment Eye Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Posterior Segment Eye Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Posterior Segment Eye Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Posterior Segment Eye Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Posterior Segment Eye Disease Treatment Market Size (2019-2030)
9.2 Latin America Posterior Segment Eye Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Posterior Segment Eye Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Posterior Segment Eye Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Santen Pharmaceuticals
11.1.1 Santen Pharmaceuticals Company Detail
11.1.2 Santen Pharmaceuticals Business Overview
11.1.3 Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Introduction
11.1.4 Santen Pharmaceuticals Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.1.5 Santen Pharmaceuticals Recent Development
11.2 Abbvie Inc.
11.2.1 Abbvie Inc. Company Detail
11.2.2 Abbvie Inc. Business Overview
11.2.3 Abbvie Inc. Posterior Segment Eye Disease Treatment Introduction
11.2.4 Abbvie Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.2.5 Abbvie Inc. Recent Development
11.3 Bausch Health Companies Inc.
11.3.1 Bausch Health Companies Inc. Company Detail
11.3.2 Bausch Health Companies Inc. Business Overview
11.3.3 Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Introduction
11.3.4 Bausch Health Companies Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.3.5 Bausch Health Companies Inc. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Detail
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Introduction
11.4.4 F Hoffmann-La Roche Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Detail
11.5.2 Merck & Co. Inc. Business Overview
11.5.3 Merck & Co. Inc. Posterior Segment Eye Disease Treatment Introduction
11.5.4 Merck & Co. Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.5.5 Merck & Co. Inc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Posterior Segment Eye Disease Treatment Introduction
11.6.4 Novartis AG Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.6.5 Novartis AG Recent Development
11.7 Alcon Inc.
11.7.1 Alcon Inc. Company Detail
11.7.2 Alcon Inc. Business Overview
11.7.3 Alcon Inc. Posterior Segment Eye Disease Treatment Introduction
11.7.4 Alcon Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.7.5 Alcon Inc. Recent Development
11.8 Rainbow Medical Ltd
11.8.1 Rainbow Medical Ltd Company Detail
11.8.2 Rainbow Medical Ltd Business Overview
11.8.3 Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Introduction
11.8.4 Rainbow Medical Ltd Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.8.5 Rainbow Medical Ltd Recent Development
11.9 Regeneron Pharmaceuticals Inc.
11.9.1 Regeneron Pharmaceuticals Inc. Company Detail
11.9.2 Regeneron Pharmaceuticals Inc. Business Overview
11.9.3 Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.9.5 Regeneron Pharmaceuticals Inc. Recent Development
11.10 Second Sight Medical Products Inc.
11.10.1 Second Sight Medical Products Inc. Company Detail
11.10.2 Second Sight Medical Products Inc. Business Overview
11.10.3 Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Introduction
11.10.4 Second Sight Medical Products Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.10.5 Second Sight Medical Products Inc. Recent Development
11.11 Aerie Pharmaceuticals
11.11.1 Aerie Pharmaceuticals Company Detail
11.11.2 Aerie Pharmaceuticals Business Overview
11.11.3 Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Introduction
11.11.4 Aerie Pharmaceuticals Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024)
11.11.5 Aerie Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Posterior Segment Eye Disease Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medical Treatement
Table 3. Key Players of Operation
Table 4. Global Posterior Segment Eye Disease Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Posterior Segment Eye Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Posterior Segment Eye Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Posterior Segment Eye Disease Treatment Market Share by Region (2019-2024)
Table 8. Global Posterior Segment Eye Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Posterior Segment Eye Disease Treatment Market Share by Region (2025-2030)
Table 10. Posterior Segment Eye Disease Treatment Market Trends
Table 11. Posterior Segment Eye Disease Treatment Market Drivers
Table 12. Posterior Segment Eye Disease Treatment Market Challenges
Table 13. Posterior Segment Eye Disease Treatment Market Restraints
Table 14. Global Posterior Segment Eye Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Posterior Segment Eye Disease Treatment Market Share by Players (2019-2024)
Table 16. Global Top Posterior Segment Eye Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Posterior Segment Eye Disease Treatment as of 2023)
Table 17. Ranking of Global Top Posterior Segment Eye Disease Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Posterior Segment Eye Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Posterior Segment Eye Disease Treatment Product Solution and Service
Table 21. Date of Enter into Posterior Segment Eye Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Posterior Segment Eye Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Posterior Segment Eye Disease Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Posterior Segment Eye Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Posterior Segment Eye Disease Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Posterior Segment Eye Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Posterior Segment Eye Disease Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Posterior Segment Eye Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Posterior Segment Eye Disease Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Posterior Segment Eye Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Posterior Segment Eye Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Posterior Segment Eye Disease Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Posterior Segment Eye Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Posterior Segment Eye Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Posterior Segment Eye Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Posterior Segment Eye Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Posterior Segment Eye Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Posterior Segment Eye Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Santen Pharmaceuticals Company Detail
Table 47. Santen Pharmaceuticals Business Overview
Table 48. Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Product
Table 49. Santen Pharmaceuticals Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 50. Santen Pharmaceuticals Recent Development
Table 51. Abbvie Inc. Company Detail
Table 52. Abbvie Inc. Business Overview
Table 53. Abbvie Inc. Posterior Segment Eye Disease Treatment Product
Table 54. Abbvie Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 55. Abbvie Inc. Recent Development
Table 56. Bausch Health Companies Inc. Company Detail
Table 57. Bausch Health Companies Inc. Business Overview
Table 58. Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Product
Table 59. Bausch Health Companies Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 60. Bausch Health Companies Inc. Recent Development
Table 61. F Hoffmann-La Roche Company Detail
Table 62. F Hoffmann-La Roche Business Overview
Table 63. F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Product
Table 64. F Hoffmann-La Roche Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 65. F Hoffmann-La Roche Recent Development
Table 66. Merck & Co. Inc. Company Detail
Table 67. Merck & Co. Inc. Business Overview
Table 68. Merck & Co. Inc. Posterior Segment Eye Disease Treatment Product
Table 69. Merck & Co. Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 70. Merck & Co. Inc. Recent Development
Table 71. Novartis AG Company Detail
Table 72. Novartis AG Business Overview
Table 73. Novartis AG Posterior Segment Eye Disease Treatment Product
Table 74. Novartis AG Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 75. Novartis AG Recent Development
Table 76. Alcon Inc. Company Detail
Table 77. Alcon Inc. Business Overview
Table 78. Alcon Inc. Posterior Segment Eye Disease Treatment Product
Table 79. Alcon Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 80. Alcon Inc. Recent Development
Table 81. Rainbow Medical Ltd Company Detail
Table 82. Rainbow Medical Ltd Business Overview
Table 83. Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Product
Table 84. Rainbow Medical Ltd Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 85. Rainbow Medical Ltd Recent Development
Table 86. Regeneron Pharmaceuticals Inc. Company Detail
Table 87. Regeneron Pharmaceuticals Inc. Business Overview
Table 88. Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Product
Table 89. Regeneron Pharmaceuticals Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 90. Regeneron Pharmaceuticals Inc. Recent Development
Table 91. Second Sight Medical Products Inc. Company Detail
Table 92. Second Sight Medical Products Inc. Business Overview
Table 93. Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Product
Table 94. Second Sight Medical Products Inc. Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 95. Second Sight Medical Products Inc. Recent Development
Table 96. Aerie Pharmaceuticals Company Detail
Table 97. Aerie Pharmaceuticals Business Overview
Table 98. Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Product
Table 99. Aerie Pharmaceuticals Revenue in Posterior Segment Eye Disease Treatment Business (2019-2024) & (US$ Million)
Table 100. Aerie Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Posterior Segment Eye Disease Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Posterior Segment Eye Disease Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medical Treatement Features
Figure 4. Operation Features
Figure 5. Global Posterior Segment Eye Disease Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Posterior Segment Eye Disease Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Posterior Segment Eye Disease Treatment Report Years Considered
Figure 11. Global Posterior Segment Eye Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Posterior Segment Eye Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Posterior Segment Eye Disease Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Posterior Segment Eye Disease Treatment Market Share by Players in 2023
Figure 15. Global Top Posterior Segment Eye Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Posterior Segment Eye Disease Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Posterior Segment Eye Disease Treatment Revenue in 2023
Figure 17. North America Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Posterior Segment Eye Disease Treatment Market Share by Country (2019-2030)
Figure 19. United States Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Posterior Segment Eye Disease Treatment Market Share by Country (2019-2030)
Figure 23. Germany Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Posterior Segment Eye Disease Treatment Market Share by Region (2019-2030)
Figure 31. China Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Posterior Segment Eye Disease Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Posterior Segment Eye Disease Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Posterior Segment Eye Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Santen Pharmaceuticals Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 46. Abbvie Inc. Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 47. Bausch Health Companies Inc. Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 48. F Hoffmann-La Roche Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 49. Merck & Co. Inc. Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 50. Novartis AG Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 51. Alcon Inc. Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 52. Rainbow Medical Ltd Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 53. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 54. Second Sight Medical Products Inc. Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 55. Aerie Pharmaceuticals Revenue Growth Rate in Posterior Segment Eye Disease Treatment Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
